Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency

Phase 3

Completed

• Conditions: Iron Deficiency Anemia
• Interventions: Drug: Iron; Drug: Herbal medicine

• Registration Number: NCT01414374
• Lead Sponsor: Casa Espirita Terra de Ismael

Brief Summary

The study aims to investigate the prevalence of genetic polymorphisms in adults with iron deficiency and anemia, and the responses to two different treatments: iron sulphate and a composite herbal medicine (Hibiscus sabdariffa plus Centella asiatica). The main outcome will be hemoglobin, measured before and after 6 weeks.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-08-09
• Study First Submitted QC: 2011-08-10
• Study First Posted: 2011-08-11
• Study Start: 2012-01
• Primary Completion: 2012-12
• Study Completion: 2013-03
• Status Verified: 2015-02
• Last Update Submitted: 2015-02-12
• Last Update Posted: 2015-02-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Age > 18 y and < 50 y
• A diagnostic of iron deficient anemia

Exclusion Criteria

• Severe anemia
• Treatment interruption for more than 25% of the 6 weeks
• New onset severe adverse symptoms or events
• Patient's request

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Iron	Iron	-
Herbal	Herbal medicine	-

Primary Outcome Measures

Name	Time	Method
Hemoglobin	6 weeks	Hemoglobin will be measured before treatment and after 6 weeks of treatment

Trial Locations

Locations (1)

Laboratorio M. F. Teixeira; 🇧🇷 Monte Santo de Minas, Minas Gerais, Brazil